# Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder

> **NCT03087578** · NA · WITHDRAWN · sponsor: **University Hospitals Cleveland Medical Center**

## Conditions studied

- Overactive Bladder

## Interventions

- **OTHER:** electroacupncture
- **DRUG:** Mirabegron 50 MG [Myrbetriq]

## Key facts

- **NCT ID:** NCT03087578
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-09-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never started
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087578, "Comparison of Electroacupuncture to Mirabegron for Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03087578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*